Atreca, Inc. Rings the Closing Bell
ABOUT THIS EVENT
Atreca, Inc. (Nasdaq: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, John Orwin, President & CEO, rang the Closing Bell.